Thu, March 17, 2022
Wed, March 16, 2022
Tue, March 15, 2022

Gregory Renza Maintained (APRE) at Hold with Decreased Target to $80 on, Mar 16th, 2022

Gregory Renza of RBC Capital, Maintained "Aprea Therapeutics, Inc." (APRE) at Hold with Decreased Target from $100 to $80 on, Mar 16th, 2022.

Gregory, nor any peers, have made any analyst calls on APRE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30